Author Correction: Engineering self-deliverable ribonucleoproteins for genome editing in the brain

Journal Article · Wed May 01 04:00:00 EDT 2024 · Nature Communications

DOI:https://doi.org/10.1038/s41467-024-48087-6· OSTI ID:2396862

Chen, Kai ^[1]; Stahl, Elizabeth C. ^[1]; Kang, Min Hyung ^[1]; Xu, Bryant ^[1]; Allen, Ryan ^[1]; Trinidad, Marena ^[1]; Doudna, Jennifer A. ^[2]

---

1. Univ. of California, Berkeley, CA (United States)
2. Univ. of California, Berkeley, CA (United States); Gladstone Institutes, San Francisco, CA (United States); Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA (United States); Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States)

Correction to: Nature Communicationshttps://doi.org/10.1038/s41467-024-45998-2, published online 26 February 2024. In the Acknowledgements section of this article, the grant number relating to National Institutes of Health funding to J.A.D. was incorrectly given as RM1HG009490 and should have been U19NS132303. The grant number 2334028 relating to the National Science Foundation funding to J.A.D. was omitted. Funding from Hampton University Summer Undergraduate Research Program, Mr. Li Ka Shing, Emerson Collective and the Innovative Genomics Institute (IGI) were omitted. The original article has been corrected.

• Research Organization: Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States)
• Sponsoring Organization: USDOE Office of Science (SC)
• Grant/Contract Number: AC02-05CH11231
• OSTI ID: 2396862
• Journal Information: Nature Communications, Journal Name: Nature Communications Journal Issue: 1 Vol. 15; ISSN 2041-1723
• Publisher: Nature Publishing Group
• Country of Publication: United States
• Language: English

Related Subjects

60 APPLIED LIFE SCIENCES
CRISPR-Cas9 genome editing
biotechnology
drug delivery
genetic engineering
peptides